Blood Coagul Fibrinolysis
Blood CoagulationCalciumCarbon Monoxide
Dr. Matthew Robert Arkebauer, DO
NPI1801148697PAC ID3476832106
- Medicare services, 2024
- 46,290
- Medicare patients, 2024
- 463
- Part D claims, 2024
- 5,849
- Publications
- 6
- Hospital affiliations
- 3
- Practice address
- 2848 S Delsea Dr Suite 2c Suite 2c, Vineland, NJ 08360-7042
- Practice phone
- Call (856) 749-9090
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Arthritis & Rheumatology Associates Of South Jersey
Primary care practice · Vineland, New Jersey
Find Dr. Arkebauer's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew Robert Arkebauer is a rheumatologist in Vineland, New Jersey
Dr. Arkebauer practices at Arthritis & Rheumatology Associates Of South Jersey in Vineland, New Jersey.
Dr. Arkebauer's NPI, 1801148697, was assigned on October 4, 2012. Dr. Arkebauer graduated from Philadelphia College of Osteopathic Medicine in 2011. Dr. Arkebauer holds New Jersey license 25MB09849200.
NPI and contact details
- NPI
- 1801148697NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3476832106
- NPI enumeration date
- October 4, 2012
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (856) 749-9090
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 41
- Medical school graduation
- 2011
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Matthew Robert Arkebauer practices at Arthritis & Rheumatology Associates of South Jersey in Vineland, New Jersey
Dr. Arkebauer's primary practice is Arthritis & Rheumatology Associates of South Jersey, at 2848 S Delsea Dr Suite 2c Suite 2c, Vineland, NJ 08360-7042. The practice phone is (856) 749-9090.
- Arthritis & Rheumatology Associates of South Jersey2848 S Delsea Dr Suite 2c Suite 2c, Vineland, NJ 08360-7042Phone(856) 749-9090
Source: Dmand AI Affiliation Data
Dr. Matthew Robert Arkebauer is affiliated with 4 sites of care and 1 medical group
Dr. Arkebauer's primary practice is Arthritis & Rheumatology Associates Of South Jersey in Vineland, New Jersey. Dr. Arkebauer is also affiliated with Inspira Medical Center Vineland. The medical group on file is Arthritis & Rheumatology Associates of South Jersey, P.C. Dmand AI also links Dr. Arkebauer to 2 more hospitals, each named with a free account.
Arthritis & Rheumatology Associates Of South JerseyPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Matthew Robert Arkebauer's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arkebauer practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Arthritis & Rheumatology Associates Of South Jersey | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Arkebauer practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew Robert Arkebauer is one of 234 rheumatologists in New Jersey
Rheumatology is Dr. Arkebauer's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Arkebauer is licensed in New Jersey.
Specialties and state licenses
- Rheumatology, New JerseyPrimary
Rheumatologists near Dr. Arkebauer
Counts of rheumatologists with a Dmand AI profile, by place and practice. Each opens the list.
234rheumatologists in New Jersey
4rheumatologists in Vineland
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew Robert Arkebauer billed Medicare for 46,290 services in 2024
CMS data shows 46,290 Medicare services from Dr. Arkebauer across 28 procedure codes in 2024, for 463 Medicare patients. Medicare paid $151,632 for them. Every service was in an office.
Medicare services, 202446,290
Medicare patients463
Paid by Medicare$151,632
Procedure codes28
Dr. Arkebauer's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 24,1272024: 43,97582%
- Office and hospital visits
- 2023: 9972024: 9515%
- Surgery
- 2023: 8142024: 70114%
- Imaging
- 2023: 1,2372024: 51958%
- Tests and treatments
- 2023: 8552024: 11187%
- Other services
- 2023: 832024: 3360%
Dr. Arkebauer compared with the New Jersey median for rheumatologists, 2024
- Dr. Arkebauer
- New Jersey median
- Medicare services
- 46,290vs 3,99511.6 times
- Medicare patients
- 463vs 26674% above
- Part D claims
- 5,675vs 1,0645.3 times
Medians across 237 rheumatologists in New Jersey with Dmand AI profiles that report each measure.
Dr. Arkebauer's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Arkebauer?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Arkebauer and other rheumatologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Matthew Robert Arkebauer treated 463 Medicare patients in 2024, average age 70
CMS counts 463 Medicare patients who saw Dr. Arkebauer in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have arthritis, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Arkebauer's median patient age at 64, with 72% women.
Medicare patients, 2024463
Average age70
Average risk score1.47
Also on Medicaid34%
Dr. Arkebauer's Medicare patients by age, 2024
Dr. Arkebauer's Medicare patients by sex, 2024
- Women32670%
- Men13730%
Chronic conditions among Dr. Arkebauer's Medicare patients, 2024
- Arthritis75%
- High blood pressure75%
- High cholesterol75%
- Diabetes35%
- Osteoporosis31%
- Anxiety29%
- Mood disorders27%
- COPD24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Arkebauer's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 64
Patient panel by sex, all payers
- Women72%
- Men26%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Matthew Robert Arkebauer wrote 5,849 Medicare Part D claims in 2024
In 2024, Dr. Arkebauer wrote 5,849 Medicare Part D claims for 663 patients. 96% of them were for generic drugs. CMS names the drug for 5,675 of them, across 39 drugs with 11 or more claims each, at $1,216,302 in total drug cost. In 2023, CMS named 6,072 claims across 44 drugs.
Part D claims, 20245,849
Drugs named by CMS39
Total drug cost$1.2M
Part D patients663
Dr. Arkebauer's Part D claims by kind of drug, 2024
- Generic5,595 claims96%
- Brand-name and other254 claims4%
Dr. Arkebauer's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Arkebauer's Part D claims, 2024
- Opioids11%616 of 5,849 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6,0722024: 5,6757%
Drugs named by CMS: 39 in 2024, 44 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Matthew Robert Arkebauer scored 0 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Arkebauer for performance year 2024, reported individually. Dr. Arkebauer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Arkebauer's MIPS scores, performance year 2024
- 0of 100Final score
- 0of 100Quality
- 0of 100Improvement Activities
- 0of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find rheumatologists like Dr. Arkebauer by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew Robert Arkebauer has 6 publications on record
Dmand AI links 6 papers to Dr. Arkebauer, published from 2011 to 2015. The most frequent topics are Blood Coagulation, Carbon Monoxide and Organometallic Compounds. Dr. Arkebauer has published most often in Blood Coagul Fibrinolysis. Dr. Arkebauer's most frequent co-authors are Saninuj Nini Malayaman, MD and Stephen Soloway, MD, FACP, FACR, CCD.
Papers6
Years published2011 to 2015
Topics Dr. Arkebauer writes about most
- Blood Coagulation
- Carbon Monoxide
- Organometallic Compounds
- Plasma
- Rabbits
- Thrombelastography
Dr. Arkebauer's most frequent co-authors
Recent publications by Dr. Arkebauer
Blood Coagul Fibrinolysis
Blood CoagulationCarbon MonoxideFibrinolysis
J Clin Rheumatol
BiopsyCalciphylaxisDebridement
See who Dr. Arkebauer researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Arkebauer works with, so you can find a warm path to the right rheumatologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Matthew Robert Arkebauer received $3,667 in industry payments from 2016 to 2025
CMS Open Payments shows 203 general payments to Dr. Arkebauer from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $762.
General payments to Dr. Arkebauer by program year, 2016 to 2025
General payments to Dr. Arkebauer by kind, 2016 to 2025
$3.7Kin total
- Food and beverage$3,49795%
- Education$1705%
Companies that paid Dr. Arkebauer the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Matthew Robert Arkebauer graduated from Philadelphia College of Osteopathic Medicine
Dr. Arkebauer graduated from Philadelphia College of Osteopathic Medicine in 2011.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Matthew Robert Arkebauer's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew Robert Arkebauer
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew Robert Arkebauer's NPI number?
Dr. Matthew Robert Arkebauer's NPI number is 1801148697. It was assigned on October 4, 2012, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew Robert Arkebauer?
Dr. Matthew Robert Arkebauer is a rheumatologist in Vineland, New Jersey. The primary specialty in the NPI Registry is Rheumatology Physician (taxonomy code 207RR0500X).
Where does Dr. Matthew Robert Arkebauer practice?
Dr. Arkebauer practices at 2848 S Delsea Dr Suite 2c Suite 2c, Vineland, NJ 08360-7042. Dr. Arkebauer's primary practice is Arthritis & Rheumatology Associates Of South Jersey in Vineland, New Jersey. Dmand AI also links Dr. Arkebauer to 2 hospitals.
What is Dr. Matthew Robert Arkebauer's office phone number?
The practice phone on file for Dr. Arkebauer is (856) 749-9090.
What is Dr. Matthew Robert Arkebauer's medical license number?
Dr. Arkebauer holds New Jersey license 25MB09849200.
Which hospitals is Dr. Matthew Robert Arkebauer affiliated with?
Dr. Arkebauer is affiliated with Inspira Medical Center Vineland. Dmand AI links Dr. Arkebauer to 2 more hospitals.
What medical group is Dr. Matthew Robert Arkebauer part of?
Dr. Arkebauer is linked to Arthritis & Rheumatology Associates of South Jersey, P.C.
Does Dr. Matthew Robert Arkebauer accept Medicare?
Yes. CMS data shows Dr. Arkebauer billed Medicare for 46,290 services in 2024, and Dr. Arkebauer accepts Medicare assignment.
What is Dr. Matthew Robert Arkebauer's MIPS score?
Dr. Arkebauer's MIPS final score for performance year 2024 is 0 out of 100, reported individually.
How many Medicare patients does Dr. Matthew Robert Arkebauer see?
CMS counts 463 Medicare patients who saw Dr. Arkebauer in 2024, with an average age of 70.
Show 7 more questionsShow fewer questions
What services does Dr. Matthew Robert Arkebauer bill to Medicare?
In 2024, Dr. Arkebauer's most billed Medicare services were injected or infused drug (J1010), injected or infused drug (J0897) and office visit, established patient (99213).
Where did Dr. Matthew Robert Arkebauer go to medical school?
Dr. Arkebauer graduated from Philadelphia College of Osteopathic Medicine in 2011.
What drugs does Dr. Matthew Robert Arkebauer prescribe most?
In 2024 Medicare Part D data, Dr. Arkebauer's most prescribed drugs by claims were Methotrexate, Methylprednisolone and Tramadol HCl.
Has Dr. Matthew Robert Arkebauer received payments from drug or device companies?
CMS Open Payments shows $3,667 in general payments to Dr. Arkebauer from 27 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Matthew Robert Arkebauer been practicing?
Dr. Arkebauer graduated from medical school in 2011, 15 years ago.
Does Dr. Matthew Robert Arkebauer do research?
Dmand AI links 6 publications to Dr. Arkebauer, published from 2011 to 2015.
Who does Dr. Matthew Robert Arkebauer publish with?
Dr. Arkebauer's most frequent co-authors are Saninuj Nini Malayaman, MD (2 shared papers) and Stephen Soloway, MD, FACP, FACR, CCD (1 shared paper).
Selling to rheumatology practices?
See rheumatologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card